SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form CORRESP - Correspondence:
SEC Accession No. 0001607062-20-000256
Filing Date
2020-09-03
Accepted
2020-09-03 16:08:11
Documents
15

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 7713
2 filename2.htm CORRESP 142655
3 filename3.htm CORRESP 86777
4 filename4.htm CORRESP 122845
5 filename5.htm CORRESP 3464
6 filename6.htm CORRESP 15145
7 filename7.htm CORRESP 3298918
8 GRAPHIC image_001.jpg GRAPHIC 7400
9 GRAPHIC image_005.gif GRAPHIC 3750
10 GRAPHIC image_004.gif GRAPHIC 3785
11 filename11.htm CORRESP 9551
12 GRAPHIC image_002.jpg GRAPHIC 2500
13 GRAPHIC image_006.gif GRAPHIC 2059
14 GRAPHIC image_004.jpg GRAPHIC 2144
15 GRAPHIC image_005.jpg GRAPHIC 1899
  Complete submission text file 0001607062-20-000256.txt   3721040
Mailing Address 10102 USA TODAY WAY MIRAMAR FL 33025
Business Address 10102 USA TODAY WAY MIRAMAR FL 33025 416-364-2551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations